These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity's attaining more than 5% in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from July 2 through July 8, 2026 Source: InsiderScore.com
Decreases in Holdings
nCino$(NCNO)$ HMI Capital Management lowered its stake in the artificial-intelligence and cloud banking software company to 4,990,713 shares. HMI Capital Management did so through the sale of 885,000 nCino shares from June 24 through June 26 at per-share prices ranging from $14.67 to $15.72.
Following the latest sales, HMI Capital Management continues to own a 4.6% stake in nCino's outstanding stock, placing it below the 5.0% threshold that would require it to report further purchases or sales. Shares of nCino have lost roughly 31% since the beginning of this year.
Oruka Therapeutics(ORKA) Fairmount Funds Management lowered its stake in the clinical-stage antibody therapeutics developer to 14,572,917 shares. Fairmount did so through the sale of 3,553,410 Oruka Therapeutics shares in a block trade on July 1 at a price of $84.43 per share. Following the latest sale, Fairmount continues to own a 19.5% stake in Oruka's outstanding stock. Shares of Oruka have gained about 191.6% so far this year.
Enliven Therapeutics$(ELVN)$ OrbiMed Advisors lowered its stake in the clinical-stage precision oncology company to 6,774,507 shares. OrbiMed did so through the sale of 891,255 Enliven Therapeutics shares on June 22 at per share prices ranging from $45.00 to $45.38.
Following the latest sales, OrbiMed continues to own a 9.5% stake in Enliven Therapeutics' outstanding stock. Shares of Enliven have gained roughly 213.2% since the beginning of this year.
El Pollo Loco Holdings(LOCO) Biglari Capital lowered its stake in the chicken-focused fast-food chain to 4,124,701 shares. Biglari did so through the sale of 364,546 El Pollo Loco shares from June 26 through July 2 at per share prices ranging from $16.50 to $17.40. Following the latest sales, Biglari continues to own a 13.5% stake in El Pollo's outstanding stock. El Pollo shares have gained approximately 54.8% this year.
NN $(NNBR)$ Corre Partners Management reduced its stake in the high-precision components and assemblies manufacturer to 2,153,637 shares. Corre did so through the sale of 2,233,028 NN shares from June 1 through June 30 at prices ranging from $2.90 to $4.25 a share. Following the latest sales, Corre owns a 4.0% stake in NN's outstanding stock, placing it below the 5.0% threshold which would require it to report further purchases or sales. NN shares have gained roughly 153.7% this year.
Increases in Holdings
Alvotech(ALVO) Celtic Holdings raised its stake in the biosimilars developer to 107,450,988 shares. Celtic did so through the purchase of 10,133,333 Alvotech shares on June 26 at a price of $3.75 a share. Celtic now owns a 27.5% stake in Alvotech's outstanding stock.
Email: editors@barrons.com
This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
July 10, 2026 19:26 ET (23:26 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments